Keywords: سیلوستازول; Cilostazol; Vascular dementia; White matter disease; Gene microarray;
مقالات ISI سیلوستازول (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: سیلوستازول; Cilostazol; pneumonia; cerebral infarction; acute phase;
Keywords: سیلوستازول; Cilostazol; Ursodeoxycholic acid; Liver damage; Albino rats;
Keywords: سیلوستازول; Cilostazol; Obesity; AngiotensinII; Diastolic dysfunction; HFpEF; TGF-β; PKM2; Ciloz; Cilostazol; AngII; AngiotensinII; HFD; High Fat Diet; FS; Fraction Shortening; EF; Ejection Fraction; HFpEF; Heart failure with Preserved Ejection Fraction; PKM2; Pyruv
Keywords: سیلوستازول; Cilostazol; Enzymatically modified isoquercitrin; Reactive oxygen species; Colorectal cancer; Murine azoxymethane/dextran sodium sulphate-induced colorectal carcinoma model; AC; anthocyanin; ACF; aberrant crypt foci; ALA; α-lipoic acid; AOM; azoxymethane
Keywords: سیلوستازول; Cilostazol; Solvent-evaporated solid dispersion; Solvent-wetted solid dispersion; Surface-attached solid dispersion; Solubility; Crystallinity; Oral bioavailability;
Keywords: سیلوستازول; Cilostazol; Diabetes mellitus; Endothelial cell function; Microangiography;
Keywords: سیلوستازول; cilostazol; hepatic transport; OATP 1B1/1B3; biliary excretion; efflux transporter; AP; apical; BL; basolateral; DMEM; Dulbecco's modified Eagle's medium; EGCG; (-)-epigallocatechin gallate; HEK293 cells; human embryonic kidney cells; MDCKII cells; Madi
Keywords: سیلوستازول; Aspirin; Clopidogrel; Cilostazol; Dipyridamole; Stroke;
Keywords: سیلوستازول; CAT, catalase; DCT, distal convoluted tubule; GSH, Glutathione; H&E, hematoxylin and eosin; MDA, malondialdehyde; PCT, proximal convoluted tubules; SOD, superoxide dismutaseGentamicin; Nephrotoxicity; Cilostazol; Ultrastructure; Apoptosis
Keywords: سیلوستازول; Antiplatelet agents; cilostazol; meta-analysis; ischemic stroke; transient ischemic attack;
Keywords: سیلوستازول; Contraceptive; Cilostazol; Swine; Oocyte maturation; Fertility
Keywords: سیلوستازول; Chronic cerebral hypoperfusion; Middle-aged rat; Memory loss; Cilostazol; Sildenafil; Memory recovery
Keywords: سیلوستازول; Ischemic stroke; antiplatelet therapy; cilostazol; hemorrhage; meta-analysis
Keywords: سیلوستازول; cilostazol; spinal cord; ischemia-reperfusion injury; spinal cord protection; paraplegia
Keywords: سیلوستازول; PDE3B (phosphodiesterase 3B); FGFR3 (fibroblast growth factor receptor 3); Chemosensitivity; Radiosensitivity; Cilostazol
Keywords: سیلوستازول; Peripheral arterial disease; Intermittent claudication; Supervised exercise therapy; Cilostazol; Pentoxifylline; Atherosclerotic risk factors; Ankle-brachial index;
Keywords: سیلوستازول; Mesoporous silica nanotube; Gelatin coating SNT; Cilostazol; Dissolution; Release rate;
Keywords: سیلوستازول; Bradycardia; carotid artery stenting; cilostazol; hypotension
Keywords: سیلوستازول; Intermittent claudication; Cilostazol; Outcome; Safety;
Keywords: سیلوستازول; Atherosclerotic plaque; carotid stenosis; cilostazol; magnetic resonance imaging; plaque imaging
Keywords: سیلوستازول; Aneurysm; Cilostazol; Meta-analysis; Subarachnoid hemorrhage; Systematic review; Vasospasm;
Keywords: سیلوستازول; Mouse; Cerebral ischemia; Leukocyte; Endothelial cell; Cilostazol; Brain microvessel;
Keywords: سیلوستازول; Prasugrel; Cilostazol; Platelet function tests; ST elevation myocardial infarction;
Keywords: سیلوستازول; Contraceptives; Ovulation; Immature oocytes; Superovulation; Fertility; Cilostazol;
Keywords: سیلوستازول; cilostazol; naftidrofuryl; pharmacotherapy for intermittent claudication; treatment for intermittent claudication; Pletal; Praxilene;
Keywords: سیلوستازول; Allodynia; Cilostazol; Hyperalgesia; Peripheral neuropathic pain; Vincristine;
Keywords: سیلوستازول; Cilostazol; Drug-eluting stents; Inflammation; Restenosis;
Keywords: سیلوستازول; Cilostazol; Type 1 diabetes mellitus; DES; Vessel healing;
Keywords: سیلوستازول; Cilostazol; Triple antiplatelet therapy; Drug-eluting stent; Randomized controlled trial; Meta-analysis;
Keywords: سیلوستازول; Cognitive impairment; vascular dementia; cilostazol; probucol; intracerebral hemorrhage; microbleeds; cerebral infarction; clinical trial
Cilostazol May Decrease Plasma Inflammatory Biomarkers in Patients with Recent Small Subcortical Infarcts: A Pilot Study
Keywords: سیلوستازول; Biomarkers; cilostazol; lacunar infarction; progression; small-vessel diseases; stroke outcomes;
Cilostazol alleviates streptozotocin-induced testicular injury in rats via PI3K/Akt pathway
Keywords: سیلوستازول; Cilostazol; Sildenafil; Diabetic testicular damage;
Supratherapeutic concentrations of cilostazol inhibits β-amyloid oligomerization in vitro
Keywords: سیلوستازول; Aβ; amyloid β-protein; AD; Alzheimer's disease; APP; amyloid precursor protein; APS; ammonium persulfate; αS; α-synuclein; CREB; cyclic adenosine monophosphate response element-binding protein; CSZ; cilostazol; DMTs; disease-modifying therapies; EM; e
The effect of cilostazol, a phosphodiesterase 3 (PDE3) inhibitor, on human hair growth with the dual promoting mechanisms
Keywords: سیلوستازول; DMEM; Dulbecco's modified Eagle medium; DPCs; dermal papilla cells; ERK; extracellular signal-regulated kinase; FBS; fetal bovine serum; H&E; hematoxylin and eosin; HFs; hair follicles; HGF; hepatocyte growth factor; IGF; insulin-like growth factor; IGF
Effects of açaà and cilostazol on skin microcirculation and viability of TRAM flaps in hamsters
Keywords: سیلوستازول; Myocutaneous flap; Necrosis; Tissue survival; Microcirculation; Cilostazol; Açaà berries;
MicroRNA-132 targeting PTEN contributes to cilostazol-promoted vascular smooth muscle cell differentiation
Keywords: سیلوستازول; Cilostazol; Differentiation; microRNA; PTEN; Vascular smooth muscle cell;
Phosphodiesterase-3 inhibitor cilostazol reverses endothelial dysfunction with ageing in rat mesenteric resistance arteries
Keywords: سیلوستازول; Cilostazol; Ageing; Endothelial dysfunction; Nitric oxide; EDHF; Phosphodiesterase-3;
Long-term cilostazol administration prevents age-related decline of hippocampus-dependent memory in mice
Keywords: سیلوستازول; Phosphodiesterase 3 inhibitor; Cilostazol; Memory; Aging; cAMP; 3â², 5â²-cyclic adenosine monophosphate; CREB; cAMP response element-binding protein; n.s.; not significant; PDE; phosphodiesterase; PKA; protein kinase A, cAMP-dependent protein kinase; ci
Oral quinine sulfate for the treatment of electrical storm and prevention of recurrent shocks in Brugada syndrome after failed cilostazol therapy
Keywords: سیلوستازول; Brugada syndrome; Quinine sulfate; Electrical storm; Recurrent ICD shocks; Quinidine; Cilostazol; Antiarrhythmic drugs;
Solubility of cilostazol in the presence of polyethylene glycol 4000, polyethylene glycol 6000, polyvinylpyrrolidone K30, and poly(1-vinylpyrrolidone-co-vinyl acetate) at different temperatures
Keywords: سیلوستازول; Cilostazol; Solubilization; PEG; PVP; PVP/VA;
Oral administration of cilostazol improves survival rate after rat liver ischemia/reperfusion injury
Keywords: سیلوستازول; Cilostazol; Alanine aminotransferase; Aspartate aminotransferase; Hepatocyte injury; Partial ischemia/reperfusion injury; Phosphodiesterase III inhibitor;
Anti-inflammatory effects of the selective phosphodiesterase 3 inhibitor, cilostazol, and antioxidants, enzymatically-modified isoquercitrin and α-lipoic acid, reduce dextran sulphate sodium-induced colorectal mucosal injury in mice
Keywords: سیلوستازول; ALA; α-lipoic acid; cAMP; cyclic adenosine monophosphate; cGMP; cyclic guanosine monophosphate; CZ; cilostazol; DAI; disease activity index; DSS; dextran sodium sulphate; EMIQ; enzymatically modified isoquercitrin; H&E; haematoxylin and eosin; IBD; infla
Supplementation of cilostazol during in vitro maturation enhances the meiosis and developmental competence of yak oocytes by influencing cAMP content and mRNA expression
Keywords: سیلوستازول; Cyclic AMP; Oocyte; Meiosis; Cilostazol; GSH;
Improvements in oocyte competence in superovulated mice following treatment with cilostazol: Ovulation of immature oocytes with high developmental rates
Keywords: سیلوستازول; AC; adenylyl cyclase; BWS; blocking washing solution; CG; cortical granule; CGFD; cortical granules with free domain; CGID; cortical granules with intermittent domain; CLZ; cilostazol; 8-OHdG; 8-hydroxy-2â²-deoxyguanosine; eNOS; endothelial nitric oxide
Release kinetics of highly porous floating tablets containing cilostazol
Keywords: سیلوستازول; Cilostazol; Floating; Porous; Release kinetics; Gastroretentive; Hydrophobic; Percolation threshold; Powder rheometer;
Investigation and structural elucidation of a new impurity in bulk drug of cilostazol by LC/MS/MS, FT-IR and NMR
Keywords: سیلوستازول; Cilostazol; Impurity; Phenols oxidation; LC/MS/MS; Quantification;
Development of novel cilostazol-loaded solid SNEDDS using a SPG membrane emulsification technique: Physicochemical characterization and in vivo evaluation
Keywords: سیلوستازول; Cilostazol; Solid self-nanoemulsifying drug delivery system; Shirasu porous glass membrane; Membrane emulsification; Emulsion droplet size; Solubility; Bioavailability;
Long-term cilostazol administration ameliorates memory decline in senescence-accelerated mouse prone 8 (SAMP8) through a dual effect on cAMP and blood-brain barrier
Keywords: سیلوستازول; Cilostazol; Memory; 18F-FDG PET; CREB phosphorylation; BBB; Senescence-accelerated mouse (SAM); cilostazol (PubChem ID: 2754);
Treatment with cilostazol improves clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease
Keywords: سیلوستازول; Cilostazol; Hemodialysis; Peripheral artery disease; Stroke; Prognosis